Dror Bashan is PRESIDENT AND CEO of Protalix BioTherapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Protalix BioTherapeutics, Inc.
3 Apr 24
4
Protalix BioTherapeutics, Inc.
20 Oct 23
4
Protalix BioTherapeutics, Inc.
17 Aug 23
4
Protalix BioTherapeutics, Inc.
9 Sep 22
4
Protalix BioTherapeutics, Inc.
13 Apr 22
4
Protalix BioTherapeutics, Inc.
28 Feb 22
4/A
Protalix BioTherapeutics, Inc.
14 Aug 20
4
Protalix BioTherapeutics, Inc.
13 Aug 20
4
Protalix BioTherapeutics, Inc.
2 Jul 19
3
Protalix BioTherapeutics, Inc.
2 Jul 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | PLX Protalix BioTherapeutics | Common Stock | Grant | Acquire A | Yes | No | 0 | 263,960 | 0.00 | 2,149,418 |
19 Oct 23 | PLX Protalix BioTherapeutics | Common Stock | Buy | Acquire P | No | No | 1.41 | 16,129 | 22.74 k | 132,516 |
19 Oct 23 | PLX Protalix BioTherapeutics | Common Stock | Buy | Acquire P | No | No | 1.4 | 48,387 | 67.74 k | 116,387 |
15 Aug 23 | PLX Protalix BioTherapeutics | Common Stock | Grant | Acquire A | Yes | No | 0 | 800,000 | 0.00 | 1,885,458 |